MAM
LFCR icon

Martingale Asset Management’s Lifecore Biomedical LFCR Stock Holding History

Martingale Asset Management’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-24,430
Closed -$158K – 865
2022
Q4 		$158K Hold
24,430
– – ﹤0.01% 804
2022
Q3 		$218K Hold
24,430
– – ﹤0.01% 767
2022
Q2 		$244K Buy
24,430
+1,815
+8% +$18K ﹤0.01% 773
2022
Q1 		$262K Buy
22,615
+101
+0.4% +$1.13K ﹤0.01% 749
2021
Q4 		$250K Buy
22,514
+100
+0.4% +$970 ﹤0.01% 766
2021
Q3 		$207K Buy
+22,414
New +$244K ﹤0.01% 816
2020
Q4 		– Sell
-72,314
Closed -$704K – 980
2020
Q3 		$704K Sell
72,314
-89,900
-55% -$856K 0.01% 725
2020
Q2 		$1.29M Hold
162,214
– – 0.02% 672
2020
Q1 		$1.41M Hold
162,214
– – 0.02% 580
2019
Q4 		$1.84M Sell
162,214
-1,200
-0.7% -$12.8K 0.02% 614
2019
Q3 		$1.78M Buy
163,414
+19,701
+14% +$214K 0.02% 613
2019
Q2 		$1.35M Sell
143,713
-19,000
-12% -$192K 0.01% 701
2019
Q1 		$2M Buy
162,713
+45,287
+39% +$553K 0.02% 600
2018
Q4 		$1.39M Buy
117,426
+17,500
+18% +$240K 0.02% 629
2018
Q3 		$1.44M Buy
99,926
+50,203
+101% +$694K 0.02% 637
2018
Q2 		$741K Buy
49,723
+22,805
+85% +$317K 0.01% 795
2018
Q1 		$352K Hold
26,918
– – ﹤0.01% 863
2017
Q4 		$340K Sell
26,918
-1,000
-4% -$12.6K ﹤0.01% 875
2017
Q3 		$362K Sell
27,918
-1,200
-4% -$15.8K ﹤0.01% 884
2017
Q2 		$433K Buy
+29,118
New +$405K 0.01% 843

Other funds holding LFCR

GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
VWA
Visionary Wealth Advisors O'fallon, Illinois $2.26B AUM 19.48% 1-Year Est. Return

Martingale Asset Management's LFCR Position: Q1 2023 in Review

Martingale Asset Management sold out of Lifecore Biomedical (LFCR) in Q1 2023, closing a stake of 24,430 shares — an estimated $158K sold.

Martingale Asset Management first reported a position in LFCR in Q2 2017 and held it in 20 quarters. The position peaked at $2M in Q1 2019. 82 funds tracked by Wall St. Rank hold LFCR as of Q1 2023.

  • Martingale Asset Management reported no remaining Lifecore Biomedical position as of Q1 2023 after selling out during the quarter.
  • Martingale Asset Management sold 24,430 Lifecore Biomedical shares in Q1 2023, an estimated $158K.
  • Martingale Asset Management first reported a position in Lifecore Biomedical in Q2 2017 and held it in 20 quarters.
  • Martingale Asset Management's Lifecore Biomedical position peaked at $2M in Q1 2019.
  • 82 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2023.

Based on Martingale Asset Management's 13F filing for Q1 2023, filed 12 May 2023.